By Mike Spector and Dietrich Knauth (Reuters) -Johnson & Johnson plans to pay an additional $1.1 billion to resolve tens of thousands of legal actions alleging its baby powder and other talc products caused cancer,

J&J has taken all its talc-based products off the market as of 2023 and is now using cornstarch instead. In its second-quarter results update, the company said "talc matters" had resulted in an on-paper charge of $3 billion in the first six months of the year, down from $7.1 billion in the same period of 2023.

Tort lawyer Allen Smith now backs J&J’s settlement plan after the company raised its offer to roughly $9 billion.

Johnson Johnson has added $1.1 billion to its talc settlement, raising the total to over $9 billion. The healthcare giant aims to resolve thousands of lawsuits alleging its talc products caused cancer.

Johnson & Johnson revealed plans to pay an additional $1.1 billion to its talc settlement proposal to resolve thousands of suits, alleging that its baby and other talcum powder caused cancer.

The increase would bring the total size of the offer to more than $9 billion to resolve claims the New Brunswick-based health conglomerate’s talc-based products caused ovarian cancer.

JOHNSON & Johnson plans to pay an additional US$1.1 billion to resolve tens of thousands of legal actions alleging its baby powder and other talc products caused cancer, two people familiar with the matter said.

Johnson & Johnson ($JNJ) is escalating its efforts to resolve the long-running talc lawsuit by agreeing to pay an additional $1.1 billion, the